Fredun Pharmaceuticals Limited

Fredun Pharmaceuticals Limited Announces Strategic Launch of “HORMONE RANGE PRODUCTS,” A Premium Longevity and Human Performance Therapeutics Brand

Fredun Pharmaceuticals Limited Announces Strategic Launch of “HORMONE RANGE PRODUCTS,” A Premium Longevity and Human Performance Therapeutics Brand

Mumbai (Maharashtra) [India], May 18: Fredun Pharmaceuticals Limited (BSE – FREDUN | 539730) is pleased to announce the launch of “HORMONE RANGE PRODUCTS, its premium specialty therapeutics brand focused on longevity, hormone health, recovery science, and human performance solutions. The initiative marks Fredun’s strategic entry into a rapidly expanding, high-value healthcare segment driven by increasing global demand for preventive, performance-oriented, and precision-based therapeutics. Built on a doctor-led, ethical, and evidence-backed pharmaceutical model, the hormone range products combine clinical credibility with a digital-first patient/doctor engagement ecosystem to deliver an integrated healthcare experience focused on outcomes, adherence, and long-term patient value. The range is…
Read More